（文章来源：每日经济新闻） 每经AI快讯，1月8日，上海自贸区板块盘初走高，彤程新材涨停，宝信软件涨超9%，招商轮船涨超 8%，浦东建设涨超7%，中远海能、华勤技术、申达股份跟涨。 ...

Core Viewpoint - The article emphasizes the transformation of traditional manufacturing into intelligent, green, and service-oriented manufacturing, highlighting the importance of digitalization in the industry [1]. Group 1: Company Overview - Sichuan Jiuzhou Investment Holding Group, established in 1958, has evolved from a traditional manufacturing company to include software services, focusing on digital solutions such as disaster monitoring and management systems [2][3]. - Jiuzhou Software, founded in 2022, aims to meet the digital transformation needs of traditional manufacturing clients by expanding into the information technology service sector, which offers higher value-added opportunities [3]. Group 2: Technological Advancements - The intelligent manufacturing industrial park in Mianyang, Sichuan, features over 50 unmanned devices operating under a centralized control system, leading to reduced operational costs and improved management efficiency [2]. - Jiuzhou Software has developed an intelligent networked cloud control platform tailored for the park's autonomous driving scenarios, enabling seamless integration of various unmanned devices [3][4]. Group 3: Service Model and Client Engagement - The company emphasizes the need for a shift in mindset from traditional manufacturing to a service-oriented approach, focusing on understanding client needs and providing ongoing support and upgrades [3][4]. - Continuous service upgrades are provided post-project delivery, including the development of new functionalities to adapt to the rapid advancements in autonomous driving technology [4]. Group 4: Financial Projections and Future Goals - Jiuzhou Software anticipates achieving a revenue of 1.5 billion yuan (approximately 15 million) by 2025, indicating a strong growth trajectory in the new service-oriented market [5]. - The company aims to leverage its hardware manufacturing strengths while increasing investment in service technologies and tackling key industry challenges [5].

然而，现实与愿景存在巨大落差。据前英伟达员工向媒体透露，尽管公司列出了包括宝马、西门子、富 士康和波士顿动力在内的客户名单，但极少有客户真正签约使用Omniverse Cloud服务器进行大规模模 拟。软件开发者普遍反映该平台"难用"、功能不完整且极易崩溃。软件开发者Valentin Forager表示，当 试图在虚拟环境中模拟人类活动时，系统直接崩溃，"只要尝试做一点超出其预设范围的事情，这东西 就会坏掉。" 此外，该平台的场景创建工具操作复杂且文档陈旧，导致许多技术问题难以修复。在去年11月的一次活 动中，甚至有英伟达代表承认该软件尚未准备好满足特定需求，建议客户转而使用竞争对手Unity的软 件。这种产品成熟度的不足，直接导致了云服务项目的终止。 尽管英伟达在截至10月的九个月内凭借AI芯片业务狂卷近1480亿美元营收，远超2023年同期的275亿美 元，但该公司向软硬一体化平台转型的关键尝试却遭遇重挫。 作为CEO黄仁勋进军50万亿美元制造业与物流业市场的核心赌注，其Omniverse软件业务在历经四年高 投入后，目前收益甚微，商业化进程严重滞后。 据知情人士向媒体透露，由于自2022年推出以来需求" ...

然而，这场市场风格的转变已悄然启动——自去年10月末标普500指数创下历史新高后，11月便迎来一 波抛售潮。截至周一收盘，一项追踪"七巨头"指数自10月29日以来下跌2%，而标普500其余493只成分 股指数则上涨1.8%。 智通财经APP获悉，过去三年，人工智能(AI)概念股一直主导着美国股市，推动相关板块累计上涨 78%。然而，如今越来越多的投资者认为，由"七巨头"引领的这轮上涨行情即将告一段落。 市场对AI能否真正给美国经济带来颠覆性变革、并创造丰厚利润的担忧日益加剧，这让投资者对该技 术的狂热情绪逐渐降温并转为焦虑，同时也促使资金开始涌入标普500指数中"其余"493家公司的股票， 尤其是那些有望在预期中的经济增长回暖中最大程度受益的企业。 "我把这种现象称为'AI审美疲劳'，"Yardeni Research总裁兼首席投资策略师Ed Yardeni表示，"我已经感 到厌倦，而且我猜想，很多人也对这一话题心存警惕。" 若市场风向逆转，将标志着这轮由如此少数股票主导、史上罕见的强劲行情周期的终结。自2022年 OpenAI旗下的ChatGPT惊艳投资者以来，英伟达(NVDA.US)、微软(MSFT.US ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源：证券市场周刊市场号 文 |水岸 2026年开年，超百股涨停的现象持续霸屏，银河电子、星环科技、中国卫通、北斗星通等一众标的均开 启"一边涨停一边加速主升浪"模式。 涨停股连破百家 银河电子等低位连续涨停 近期市场持续回暖，各大指数加速上行，如上证指数创近10年新高，2025年12月17日以来大涨7%；成 交量增加，1月6日成交额2.83万亿元，创近4个月新高。还有一个维度，即涨停股数量显著增多。 统计显示，A股近日涨停股数量屡超百家，如1月5日达到了128家，是此前一个交易日的2倍，1月6日则 达到了144家，为近期最高值（见表1），且为2025年5月6日（145家涨停）以来的最高值。 | | | 表I: 近期涨停股数量 | | | | --- | --- | --- | --- | --- | | 交易日 | | 上涨家数 | 涨停家数 | | | 2026/1/6 | | 4108 | 144 | 2 | | 2026/1/5 | | 4185 | 128 | 13 | | 2025/12/31 2025/12/30 11 1 ...

Core Insights - The pharmaceutical industry is at a critical juncture for high-quality development and digital transformation, with laboratory management and data governance being essential for enhancing efficiency and compliance [1] Group 1: AI Integration in Laboratory Management - Traditional manual management in laboratories is becoming inadequate due to increasing compliance demands and the need for faster R&D [2] - AI technology integrated with the SW-LIMS system automates data processing, ensuring accuracy and compliance by converting quality standards into structured data [2] - AI can automatically check formats, correct text, and verify logic in experimental records, providing real-time alerts for deviations [2] Group 2: Data Governance and Quality Improvement - High-quality data is crucial for the digital transformation of pharmaceutical companies, with the DAM platform utilizing AI for automated data governance [3] - The platform enhances data quality accuracy to over 98% by cleaning and standardizing both structured and unstructured data [3] - AI monitors compliance with regulations like GDPR and HIPAA, generating compliance reports to reduce audit burdens and costs [3] Group 3: Practical Applications and Future Plans - The AI solutions from the company have been successfully implemented in leading pharmaceutical firms, improving data quality accuracy from 75% to over 98% [4] - Future plans include developing an AI Agent platform for various high-value business scenarios and enhancing marketing automation through AI [4] - The company aims to optimize the ChatBI analysis experience, increasing intent recognition accuracy to over 90% and providing continuous support for the industry's digital transformation [4]

Core Insights - The US equity financing market in 2025 showed a significant recovery, with total financing reaching $201.8 billion, a 14.27% increase from $176.6 billion in 2024 [1][3][39] - Initial Public Offerings (IPOs) saw a notable rise, with 403 companies going public, raising $68.4 billion, marking a 67.95% increase compared to 2024 [1][14][30] - SPAC IPOs also surged, with 123 companies raising $23.4 billion, a dramatic increase of 153.75% from the previous year [1][33] - Chinese companies listed in the US primarily consisted of small to medium-sized enterprises, totaling 68 IPOs but raising only $1.1 billion, a decrease of 62.88% from 2024 [1][36] Equity Financing Overview - Total equity financing in the US market for 2025 was $201.8 billion, with IPOs contributing $68.4 billion (33.90%) and refinancings accounting for $133.4 billion (66.10%) [3][6] - The non-bank financial sector led in financing, raising $61.9 billion, followed by the pharmaceutical and biotechnology sector at $33.9 billion, and software services at $22.6 billion [9] IPO Market Trends - The IPO market in 2025 was dominated by the Nasdaq, with 313 companies raising $46.04 billion, representing 67.30% of the total IPO market [16] - The highest fundraising sector for IPOs was non-bank financials, raising $34.6 billion, followed by pharmaceuticals at $8 billion, and software services at $7.4 billion [18] - A total of 230 companies raised $1 billion or less in their IPOs, making up 57% of the total IPO count [27] Refinancing Trends - The refinancing market in 2025 totaled $133.4 billion, a slight decrease of 1.82% from 2024, with 912 refinancing events, an increase of 2.36% [39] - The Nasdaq led in refinancing events with 734 occurrences, raising $69.65 billion, while the NYSE had 125 events totaling $62.37 billion [43][45] - The non-bank financial sector was the top industry for refinancing, raising $27.3 billion, followed closely by pharmaceuticals at $25.9 billion [46] Underwriting Rankings - In the IPO underwriting space, Cantor Fitzgerald led with $6.484 billion from 34 deals, followed by Goldman Sachs with $6.354 billion from 36 deals, and Morgan Stanley with $5.956 billion from 35 deals [55][56] - For refinancing, J.P. Morgan topped the list with $21.098 billion from 91 deals, followed by Goldman Sachs with $16.393 billion from 73 deals [59][60]

Core Viewpoint - The US equity financing market in 2025 showed a significant recovery, with both the number and scale of equity financing reaching a four-year high, totaling $201.8 billion, a 14.27% increase from $176.6 billion in 2024 [2]. Group 1: Financing Scale Trends - In 2025, the total equity financing scale in the US market was $201.8 billion, up 14.27% from $176.6 billion in 2024 [5]. - The IPO financing scale reached $68.4 billion, marking a 67.95% increase from the previous year [5]. - The refinancing scale totaled $133.4 billion, which is a slight decrease of 1.82% compared to 2024 [5]. Group 2: Financing Method Distribution - In 2025, IPO financing accounted for $68.4 billion, representing 33.90% of the total equity financing, while refinancing accounted for $133.4 billion, making up 66.10% [8]. Group 3: Industry Distribution of Financing Entities - The non-bank financial sector led in financing scale with $61.9 billion, followed by the pharmaceutical and biotechnology sector at $33.9 billion, and the software services sector at $22.6 billion [12]. - In terms of financing events, the pharmaceutical and biotechnology sector had the highest number with 354 events, followed by the non-bank financial sector with 212 events [15]. Group 4: IPO Trends - A total of 403 companies successfully went public in 2025, an increase of 131 from 2024, with total financing amounting to $68.4 billion [18]. - The Nasdaq remained the leading market for IPOs, with 313 companies listed, raising $46.04 billion, which is 67.30% of the total IPO market [20]. - The highest IPO financing was achieved by Medline, raising $6.265 billion [35]. Group 5: SPAC and Chinese Companies - In 2025, 123 SPACs were listed, a significant increase of 72 from 2024, raising $23.4 billion, up 153.75% [38]. - There were 68 Chinese companies that went public in the US, raising only $1.1 billion, a decrease of 62.88% from the previous year [41]. Group 6: Refinancing Trends - The total refinancing amount in 2025 was $133.4 billion, a decrease of 1.82%, with 912 refinancing events, an increase of 2.36% from 2024 [45]. - The Nasdaq led in refinancing events with 734 occurrences, raising $69.654 billion [49]. - The non-bank financial sector had the highest refinancing amount at $27.3 billion [52]. Group 7: Underwriting Rankings - Cantor Fitzgerald topped the IPO underwriting list with $6.484 billion, followed closely by Goldman Sachs at $6.354 billion and Morgan Stanley at $5.956 billion [61]. - In refinancing, JPMorgan led with $21.098 billion, followed by Goldman Sachs at $16.393 billion and Morgan Stanley at $12.876 billion [65].

证券日报网讯 1月6日，东华软件在互动平台回答投资者提问时表示，公司重视市值管理，已制定《市 值管理制度》并将落实执行，综合运用多种方式促进投资价值合理反映公司质量；此外，公司会聚焦主 业、降本增效，提升生产效率与盈利能力，保障高质量稳定发展，更好地为股东创造回报。 （文章来源：证券日报） ...

中科创达1月6日公告，公司向银行申请回购专项贷款用于继续实施本次回购计划，并已取得招商银行股 份有限公司北京分行出具的《贷款承诺函》。截至2025年12月31日，公司通过回购专用证券账户以集中 竞价交易方式累计回购公司股份数量为68.76万股，占公司总股本的0.15%，最高成交价为69.94元/股， 最低成交价为48.65元/股，已使用资金总额为3,630.93万元（不含手续费）。公司上述回购实施情况符 合既定回购方案及相关法律法规的要求。 ...